INSM vs LH: fair value comparison
Insmed Incorporated and Labcorp Holdings Inc. · Updated 2026-10-19
INSM's estimate rests on a sector-average multiple, which TickrTrends does not publish as a verdict. Within Healthcare, INSM currently ranks higher by quality score.
| INSM | LH | |
|---|---|---|
| Verdict | Awaiting full valuation | Fairly valued |
| Last price | $96.27 | $312.15 |
| 12-month range | $91.88–$211.41 | $246.64–$339.34 |
| Rank by discount to fair value | — | #69 of 108 Healthcare |
| Rank by quality score | #135 of 301 Healthcare | #136 of 301 Healthcare |
| Quality grade | D | D |
| Leverage | Moderate | Moderate |
| Margin trend | Expanding | Stable |
| Revenue growth | High | Modest |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | Downtrend | — |
| DCF cross-check | — | Overvalued |
| 52-week position | The bottom quarter | The upper-middle quarter |
Full single-stock breakdowns: INSM fair value analysis · LH fair value analysis